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1. Introduction 
Muscarinic cholinergic receptors have now been 
characterized in a wide variety of tissues using various 
tritiated ligands [l-6]. Binding characteristics have 
proven to be similar in all of the different tissues 
studied to date for agonists as well as antagonists: 
antagonists are bound with high affinity, character- 
ized by a Hill coefficient of 1, suggesting a single class 
of receptor sites, while agonists show a lower affinity 
with a Hill coefficient of <l , suggesting a possible 
heterogeneity of binding sites. Indeed, two or possi- 
bly more components have been recognized in the 
case of strong agonists [7]. Muscarinic receptors of 
rat brain have been converted from a state of low to a 
state of high affinity for agonists by the alkylating 
reagent Nethyl maleimide without undergoing a 
change in antagonist affinity or a reduction of the 
total number of receptor sites [8,9]. We have found 
that the pharmacological characteristics of muscarinic 
receptors from bovine brain are similar to those of 
other mammalian species (unpublished results). Here 
1 report the influence of several agents, including sulf- 
hydryl reagents, on the binding properties of these 
receptors, using the potent muscarinic ligand [3H]- 
quinuclidinyl benzilate. The effect of these com- 
pounds upon the binding was different from that de- 
scribed for the rat and in particular, no effect of NEM 
on agonist binding was observed. 
Abbreviations: DTNB, 2,2’dinitro-5,5’dithiobenzoic acid; 
IAA, iodoacetamide; NEM, N-ethyl maleimide; pCMB, para- 
chloro-mercuribenzoic acid; DTE, 1,4dithioerythritol; QNB, 
quinuclidinyl benzilate 
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2. Materials and methods 
Ox brains were obtained fresh from the slaughter- 
house within 4 h of death. Binding studies were per- 
formed using a synaptosomal-P2 preparation prepared 
from the cerebral cortex at 0.02-0.06 mg protein/ml 
in 1 mM EGTA, 25 mM Na-phosphate buffer (pH 7.4). 
The binding assay was essentially as in [lo]. 
The membranes (0.2 mg protein/ml) were incu- 
bated with the various reagents for 30 min at 22°C or 
37°C as noted. The reagents were removed by centri- 
fuging at 12 000 X g for 20 min. The pellets were 
rinsed with buffer resuspended and recentrifuged be- 
fore use. When treatment with a second reagent fol- 
lowed, the procedure was repeated. Effects on spe- 
cific binding were tested at 250 pM [3H] QNB (16 Ci/ 
mmol) in the presence and absence of 100 nM atro- 
pine. Inhibition curves were performed at 50 pM 
t3H]QNB (44 Ci/mmol) at 22°C or 37°C as noted. 
3. Results 
3 .l . Specific [3H/QNB binding 
Incubation of the membrane preparation with 
IAA, DTE or DTNB at GO mM for 30 min at 22°C 
or 37’C had no effect on specific [3H]QNB binding. 
The effects of NEM and pCMB varied with tempera- 
ture: pCMB inhibited binding when incubated at both 
temperatures but to a much greater ,extent at 37’C 
(<65% at 1 mM). This contrasts with the case of rat 
brain receptors for which NEM was found not to in- 
hibit either antagonist or agonist binding. 
Saturating concentrations of agonists (10-l M) 
and antagonists ( 10e6 M) could protect quantitatively 
the receptor against the inhibitory effect of NEM 
(I mM) and pCMB (0.1 mM). The effects of various 
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combinations of reagents on bovine brain are shown 
in table 1. NEM at 1 mM and pCMB at 0.1 mM re- 
duced binding in bovine brain to 36% and 26% of 
control values, respectively, while DTE slightly in- 
creased binding. Reduction of disulfide bonds with 
5 mM DTE before NEM or pCMB treatment slightly 
increased the inhibitory effect of these two reagents 
by <IO%, DTE was able to reverse the effects of 
pCMB by -1 S-2095, while it further decreased bind- 
ing in NEM-pretreated samples. The combination of 
NEM and pCMB treatments resulted in almost 100% 
inhibition of specific [3H] QNB binding. 
3.2. Agonist and antagonist binding 
In order to decide whether the inhibitory effect 
observed on [3H]QNB binding resulted from a reduc- 
tion in the number of active sites, or in their binding 
affinity, we examined the displacement of this ligand 
by a series of muscarinic agents. After pCMB treat- 
ment, the displacement curves obtained with atropine 
or carbamylcholine were identical with control curves. 
In contrast, DTE decreased the affinity of the recep- 
tor for carbamylcholine -1 O-fold. Table 2 summa- 
rizes the inhibition constants of the receptor after 
these different treatments. 
The effect of membrane preincubation with 1 mM 
NEM (30 min at 37°C) on carbamylcholine inhibition 
Table 1 
Effects of various reagents on specific [ 3H]QNB binding 
Reagent Ox brain (% control binding) 
Contro! 100 
1 mM NEM 36 
0.1 mM pCMB 26 
DTE (5 mM) 110 
DTEPNEM 29 
DTE-pCMB 20 
NEM -DTE 14 
pCMB-DTE 40 
NEMppCMB 3 
pCMB-NEM 5 
Membranes were incubated with the appropriate reagents for 
30 min at 37°C. Reagents were removed by centrifugation, 
when a second treatment followed, the procedure was re- 
peated as in section 2. Binding was assayed at 37°C with 
250 pM [ 3H]QNB t 100 nM atropine. Data is represented as % 
specific [‘H]QNB binding. The values represented are from 
a typical experiment, absolute values varied -10% from ex- 
periment to experiment, but the trends remained the same. 
Experiments were performed at least 3 times 
of [3H]QNB binding is illustrated in fig.1 for rat and 
bovine brain preparations. Binding studies in this 
series of experiments were performed at 22°C and 
37’C: there was little difference in the affinities of 
control preparations for agonists at these two temper- 
Table 2 
Effects of various reagents on agonist and antagonist inhibition of [3H]QNB binding (50 PM) 
at 22°C and 37°C in rat and ox brain 
Reagent 70 Specific Species Ki (M) carbamylcholine Ki (M) atropine 
binding - 
22Oc 37°C 22°C 37°C 
Control 100 ox 1.1 x lo-’ 2.5 x 1O-5 1.4 X IO-” 2 x lo-l0 
Rat 1.1 x 1o-5 1.4 x 1o-5 2 x lo-lo 2.5 x lo-lo 
1 mM NEM 35+10 ox 1.1 x 10-s 1.1 x 1o-5 1.1 x lo-l0 2.8 X lo-” 
100 Rat 1.4 x 1o-6 1.1 x 10-s - 
0.1 mM pCMB 25*10 ox _ 1.7 x 10-S - 5.7 x 1o-‘o 
5 mM DTE lOOi 10 ox _ 1.1 x 10-4 - 2.5 x lo-‘O 
Inhibition constants (Ki) for carbamylcholine were calculated from the curves shown in fig.1. 
The Ki was calculated from the equation: 
ID,, 
Ki = 1 + C/Kd 
where C is the concentration of radioactive ligand (50 pM) and Kd its dissociation constant 
(20 pM for [ 3H]QNB as calculated from Scatchard analysis and kinetic data (not shown)). ID,, 
values were determined graphically. Atropine inhibition curves were performed the same day 
(curves not shown). Reagent incubation was at 37°C for 30 min. Binding assays were performed 
at 22°C and 37°C as noted. % specific binding indicates the % remaining sites after reagent 
treatment 
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Fig.1. Effect of 1 nM NEM on carbamylcholine inhibition of [‘H]QNB binding at 22°C or 37°C in rat and bovine brain. The 
proportion of [SH]QNB bound, relative to that observed in the presence of 50 pM [3H]QNB alone, is plotted as a function of car- 
bamylcholine concentration. The curves are thus normalised and do not reflect the inhibition observed after incubation with NEM 
(cf. table l), which was performed at 37°C for 30 min. Inhibition curves (15 min with ligand, 45 min with 50 pM L3HJQNB) were 
performed at 22°C or 37°C. (0 -a) control; (0 -0) 1 mM NEM-treated membranes. 
atures. In all cases, the affinity of the remaining sites 
for antagonists (QNB and atropine) remained un- 
changed (data not shown). As seen in the fig.1, NEM 
treatment caused an increase in the affinity of the 
receptor from rat brain for carbamylcholine, shifting 
the Ki -1 O-fold if binding was performed at 22°C. 
This effect was not observed however when the bind- 
ing was performed at 37°C. For bovine brain mem- 
branes, no significant change could be detected at 
either 22°C or 37°C. 
4. Discussion 
We have studied the influence of various reagents 
on bovine brain muscarinic receptors. In agreement 
with the results in [9] we found that NEM pretreat- 
ment at 37°C of a rat brain membrane preparation in- 
creased receptor affinity for the agonist carbamyl- 
choline, the Ki being shifted from IO-’ --10m6 M. 
However, this effect was only observed when binding 
was carried out at 22°C but not at 37’C. This indi- 
cates that not only the accessibility of affected groups 
is temperature dependent but also that their role in 
agonist binding is influenced by temperature. The in- 
crease in agonist affinity has been interpreted [8,9] 
as a reflection of the conversion of low affinity to 
high affinity conformation. Our results do not allow 
us to decide whether the characteristics of the site ob- 
served after NEM reaction are identical to those of 
the high affinity component of the control. 
The effects observed with the various reagents ex- 
amined on muscarinic binding in bovine brain differ 
in several respects from that obtained in rat brain. 
NEM causes an inhibition of specific QNB binding 
(without a corresponding change in affinity) in ox 
brain, but not in rat brain. In addition, we did not ob- 
serve any significant change in agonist affinity after 
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NEM treatment, whether binding was performed at 
22°C or 37°C. The protection observed in the pres- 
ence of an excess of agonist (IO-’ M carb~ylcholine) 
or antagonist (10m6 M atropine) against inhibition by 
NEM and pCMB implies that the reactive groups, 
which are probably sulfhydryl groups, must be direct- 
ly or allosterically involved in the binding. Treatment 
with DTE, which had little effect on binding in rat 
brain, caused a decrease in receptor affinity for ago- 
nists in ox brain. This suggests the presence of disulfide 
bonds in the receptor. DTE was also able to reverse 
-20% of the inhibition caused by pCMB while it fur- 
ther inhibited binding in membranes pretreated with 
NEM. Finally, pretreatment with NEM did not pro- 
tect against subsequent in~bition by &MB and vice 
versa. Thus, the modifications observed with the suif- 
hydryl reagents reveal a clear difference between 
bovine and rat brain muscarinic receptors, in spite 
of the similarity of their pharmacological binding 
characteristics. 
Our results indicate that it may be important to 
examine the biochemical properties of muscarinic re- 
ceptors from different species before generalizing on 
the importance of sulfhydryl groups in receptor- 
ligand interaction. Such differences must be taken 
into account in biochemical studies of muscarinic re- 
ceptors and may provide the basis for interesting 
comparisons regarding the functional role of essential 
groups in the receptor proteins. 
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